Overview

The Gene Technology Act 2000, enacted by the Australian Parliament, was introduced to address the need for a robust regulatory framework governing the use of gene technology in Australia. This legislation established the Gene Technology Regulatory System, overseen by the Gene Technology Regulator, to safeguard human health and environmental safety by identifying and managing risks associated with gene technology. The Act allows for the assessment and approval of applications for genetically modified organisms (GMOs) through a rigorous evaluation process that includes the preparation of a Risk Assessment and Risk Management Plan (RARMP). This document is fundamental in determining whether a GMO poses a negligible risk to human health and the environment. The Act’s policy objective is to facilitate the safe and responsible use of gene technology while ensuring public confidence and protecting ecological integrity. The 2015 invitation to comment on a genetically modified cotton field trial exemplifies the Act's application, demonstrating the Regulator's commitment to transparency and public consultation in the decision-making process.

Scope and Application

The legislation pertains to a proposed genetically modified (GM) cotton field trial and the regulatory framework under which it will be assessed and potentially approved. Specifically, it applies to Bayer CropScience Pty Ltd, the entity seeking a licence for the trial, and the Gene Technology Regulator, the authority responsible for overseeing the assessment and decision-making process. This legislation is situated within the Commonwealth jurisdiction, as it involves the national gene technology regulatory system designed to safeguard public health and environmental safety by managing risks associated with gene technology. The proposed trial involves the limited and controlled release of cotton genetically modified for insect resistance and herbicide tolerance, and it is intended to take place at designated sites in New South Wales, Queensland, and Western Australia between July 2015 and July 2021. The application process includes a public consultation period where submissions can be made to the Office of the Gene Technology Regulator, and the final decision on whether to issue the licence will be based on the Risk Assessment and Risk Management Plan (RARMP) developed through this process. The legislation does not specify exclusions or exemptions but implies that any approval would be contingent upon the assessment of risks and the implementation of appropriate regulatory conditions.

Key Provisions

The main operative sections of this legislation pertain to the assessment and potential approval of a genetically modified (GM) cotton field trial. Section 1 outlines the purpose of the trial, which is to assess the agronomic performance and pest resistance of the GM cotton, evaluate crosses with non-GM commercial cotton, and produce seed for future releases. Section 2 specifies the trial's geographic scope, with proposed sites in New South Wales, Queensland, and Western Australia, and the trial's duration from July 2015 to July 2021. The maximum planting area for the trial is also defined, with an initial limit of 140 hectares in the first year, expanding to 600 hectares annually in the following five years. Importantly, Section 3 notes that the GM cotton would not be used for human food or animal feed. The obligations and requirements imposed by this legislation are primarily on Bayer CropScience Pty Ltd, the entity applying for the licence to conduct the GM cotton field trial. According to Section 4, the company must adhere to the draft licence conditions, which are designed to limit the trial's size, location, and duration, and to restrict the spread and persistence of the GMOs and the introduced genetic material. Section 5 requires Bayer CropScience to prepare a Risk Assessment and Risk Management Plan (RARMP) that will be reviewed by the Regulator. The company must also ensure that the GM cotton is not used in human food or animal feed, as outlined in Section 3. Section 6 details the potential consequences for non-compliance with the conditions set forth in the legislation. While the specific offences and penalties are not explicitly stated in the document, it is implied that any breach of the licence conditions or failure to adhere to the RARMP could result in legal action. The penalties for such breaches could include fines, imprisonment, or both, depending on the severity of the offence and the specific provisions of the relevant legislation. However, the exact maximum penalties are not provided in the text.